Success Metrics

Clinical Success Rate

50.0%

Based on 1 completed trials

Completion Rate

50%(1/2)

Active Trials

1(33%)

Results Posted

100%(1 trials)

Terminated

1(33%)

Phase Distribution

Ph phase_4

33%

Ph not_applicable

33%

Ph phase_1

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

Phase 4Post-market surveillance

1(33.3%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Terminated(1)

Detailed Status

Terminated1

Completed1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (33.3%)

Phase 41 (33.3%)

N/A1 (33.3%)

Trials by Status

terminated133%

completed133%

recruiting133%

Recent Activity

1 active trials

Showing 3 of 3

recruitingphase_1

Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease

NCT06158620

terminatedphase_4

Celecoxib Efficacy And Safety Versus Diclofenac In Acute Pain Due To Cervical Sprain Related To A Traffic Accident

NCT00894790

completednot_applicable

Effect of Topical and Oral Diclofenac on Pain Related to Intravitreal Injections

NCT02837770

Clinical Trials (3)

Showing 3 of 3 trials

NCT06158620Phase 1

Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease

Recruiting

NCT00894790Phase 4

Celecoxib Efficacy And Safety Versus Diclofenac In Acute Pain Due To Cervical Sprain Related To A Traffic Accident

Terminated

NCT02837770Not Applicable

Effect of Topical and Oral Diclofenac on Pain Related to Intravitreal Injections

Completed

All 3 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 3